Meloxicam Pharmaceutical Composition and Application

ChangeBridge: Patent Apps - Therapeutics (A61P)

Published March 26th, 2026

Detected March 27th, 2026

Summary

The USPTO has published a patent application (US20260083748A1) for a pharmaceutical composition containing meloxicam, a composite solvent, and an acidic pH regulator. The assignee is Beijing Tide Pharmaceutical Co., Ltd. This application details a preparation method and its application, focusing on a formulation that avoids organic solvents for increased safety and reduced environmental impact.

View original document View source feed page

What changed

The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260083748A1, filed by Beijing Tide Pharmaceutical Co., Ltd. The application describes a pharmaceutical composition containing meloxicam, a composite solvent (including a polymer compound like cyclodextrin derivatives), and an acidic pH regulator. Notably, the composition is designed to be free of organic solvents, aiming to enhance drug safety by avoiding adverse reactions and to reduce environmental pollution during manufacturing.

This publication represents a new intellectual property filing related to drug formulation. While patent applications do not impose direct compliance obligations on other entities, they signal potential future market exclusivity for the assignee's technology. Companies involved in the development or manufacturing of meloxicam-based therapeutics should be aware of this filing as it may impact future product development and market entry strategies. No immediate compliance actions are required for other entities based solely on this patent application publication.

Source document (simplified)

← USPTO Patent Applications

PHARMACEUTICAL COMPOSITION CONTAINING MELOXICAM, A PREPARATION METHOD, AND AN APPLICATION THEREOF

Application US20260083748A1 Kind: A1 Mar 26, 2026

Assignee

Beijing Tide Pharmaceutical Co., Ltd.

Inventors

Wanjun LIU, Jingjing ZHANG, Zhibing ZHANG, Zaiying WANG, Di LU, Zhiyang YUE, Leling GAN

Abstract

The present invention provides a pharmaceutical composition containing meloxicam, a preparation method thereof, and an application thereof. The pharmaceutical composition includes meloxicam, a composite solvent, and an acidic pH regulator. The composite solvent includes a polymer compound, an alkaline compound, and an aqueous solution. The polymer compound is selected from cyclodextrin or synthetic cyclodextrin and derivatives thereof. The meloxicam composition of the present invention does not contain any organic solvent, which can effectively avoid generation of adverse reactions of pharmaceutical formulations, make drug use safer, and at the same time also reduce the environmental pollution during the preparation process of the drug.